|
|
Volumn 256, Issue 12, 2009, Pages 2094-2096
|
|
Infliximab in the treatment of rheumatoid meningoencephalitis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID DERIVATIVE;
CYCLOPHOSPHAMIDE;
GADOLINIUM;
INFLIXIMAB;
METHOTREXATE;
RHEUMATOID FACTOR;
SALAZOSULFAPYRIDINE;
ADULT;
ANTIBODY DETECTION;
APATHY;
ATAXIA;
ATTENTION DISTURBANCE;
BRAIN DYSFUNCTION;
CASE REPORT;
CEREBROSPINAL FLUID ANALYSIS;
CONTRAST ENHANCEMENT;
COORDINATION DISORDER;
CORTICOSTEROID THERAPY;
DRUG SUBSTITUTION;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
DYSARTHRIA;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
FRONTAL LOBE;
HUMAN;
HYPESTHESIA;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
LIMB WEAKNESS;
MENINGEAL BIOPSY;
MENINGITIS;
MENINGOENCEPHALITIS;
MULTIPLE CYCLE TREATMENT;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PARESIS;
PLEOCYTOSIS;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
RHEUMATOID MENINGOENCEPHALITIS;
TISSUE NECROSIS;
TREATMENT DURATION;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
VASCULITIS;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
FEMALE;
HUMANS;
IMMUNOSUPPRESSION;
MENINGOENCEPHALITIS;
MIDDLE AGED;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 71849105310
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-009-5286-0 Document Type: Letter |
|
Times cited : (9)
|
|
References (7)
|
